Strata Critical Medical, Inc.
SRTAHealthcareNASDAQMedical Care Facilities · Last scanned May 29, 2026
Scan Results
Daily timeframe1 of 4 indicators bearish as of May 28
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. The $559.8M market capitalization puts SRTA squarely in small-cap range for its industry. It operates in two segments, Logistics and Clinical.
Market Cap
$559.8M
Beta
2.15
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-0.19
EPS (Fwd)
—
ROE
-6.3%
ROA
-1.9%
Cash
$58.8M
Total Debt
$4.5M
Free CF
-$24.4M
52W Change
85.4%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $58.8M in cash comfortably exceeding the $4.5M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company is burning cash, with free cash flow at -$24.4M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -6.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $146.1M (2022) to $197.1M (2025), reflecting a 35% increase over the period.
With a beta above 1.5, SRTA tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. With cash comfortably exceeding debt, SRTA has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Strata Critical Medical, Inc. and its sector.